SFA
IONS icon

Semmax Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Semmax Financial Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.29K Hold
79
– – ﹤0.01% 318
2025
Q1 		$2.55K Hold
79
– – ﹤0.01% 313
2024
Q4 		$2.4K Hold
79
– – ﹤0.01% 287
2024
Q3 		$2.98K Hold
79
– – ﹤0.01% 274
2024
Q2 		$3.71K Hold
79
– – ﹤0.01% 299
2024
Q1 		$3.07K Sell
79
-3
-4% -$143 ﹤0.01% 274
2023
Q4 		$3.97K Hold
82
– – ﹤0.01% 267
2023
Q3 		$3.84K Buy
+82
New +$3.38K ﹤0.01% 244
2022
Q4 		$3K Hold
84
– – ﹤0.01% 219
2022
Q3 		$4K Sell
84
-2,243
-96% -$94.5K ﹤0.01% 198
2022
Q2 		$107K Sell
2,327
-247
-10% -$9.31K 0.04% 98
2022
Q1 		$95K Sell
2,574
-201
-7% -$6.58K 0.04% 113
2021
Q4 		$84K Sell
2,775
-656
-19% -$20.6K 0.03% 116
2021
Q3 		$115K Sell
3,431
-355
-9% -$13.4K 0.04% 109
2021
Q2 		$151K Sell
3,786
-242
-6% -$9.48K 0.05% 109
2021
Q1 		$181K Buy
4,028
+3,989
+10,228% +$222K 0.06% 104
2020
Q4 		$2K Hold
39
– – ﹤0.01% 210
2020
Q3 		$2K Hold
39
– – ﹤0.01% 209
2020
Q2 		$2K Hold
39
– – ﹤0.01% 227
2020
Q1 		$2K Hold
39
– – ﹤0.01% 222
2019
Q4 		$2K Hold
39
– – ﹤0.01% 255
2019
Q3 		$2K Hold
39
– – ﹤0.01% 246
2019
Q2 		$3K Hold
39
– – ﹤0.01% 255
2019
Q1 		$3K Hold
39
– – ﹤0.01% 389
2018
Q4 		$2K Buy
+39
New +$1.99K ﹤0.01% 394

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Semmax Financial Advisors's IONS Position: Q2 2025 in Review

Semmax Financial Advisors held its Ionis Pharmaceuticals (IONS) position steady in Q2 2025 at 79 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Semmax Financial Advisors first reported a position in IONS in Q4 2018 and has held it in 25 quarters since. The position peaked at $181K in Q1 2021. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.

  • Semmax Financial Advisors held 79 shares of Ionis Pharmaceuticals worth $3.29K as of Q2 2025.
  • Semmax Financial Advisors left its Ionis Pharmaceuticals share count unchanged in Q2 2025.
  • Ionis Pharmaceuticals made up ﹤0.01% of Semmax Financial Advisors's portfolio in Q2 2025, its #318 holding.
  • Semmax Financial Advisors first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 25 quarters since.
  • Semmax Financial Advisors's Ionis Pharmaceuticals position peaked at $181K in Q1 2021.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.